2070-DTI, a topoisomerase inhibitor produced by Streptomyces sp. strain No. 2070.

J Enzyme Inhib Med Chem

Department of Pharmaceutical Microbiology, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.

Published: December 2003

A novel inhibitor of topoisomerase II designated as 2070-DTI was isolated from the culture filtrate of Streptomyces sp. strain No. 2070. The structure was determined to be that of the known soyasaponin I on the basis of spectroscopic methods (NMR and MS). 2070-DTI strongly inhibited the decatenation activity of human placenta topoisomerase II in a noncompetitive manner, and weakly inhibited or was inert towards the relaxation activities of various topoisomerase I's and DNA-related enzymes. 2070-DTI is an inhibitor belonging to the cleavable complex-nonforming type without DNA intercalation.

Download full-text PDF

Source
http://dx.doi.org/10.1080/14756360310001613076DOI Listing

Publication Analysis

Top Keywords

streptomyces strain
8
strain 2070
8
2070-dti
4
2070-dti topoisomerase
4
topoisomerase inhibitor
4
inhibitor produced
4
produced streptomyces
4
2070 novel
4
novel inhibitor
4
inhibitor topoisomerase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!